FIELD: medicine.
SUBSTANCE: invention refers to a stable trehalose-stabilised formulation of amorphous perindopril erbumine, a method for preparation thereof consisting in the fact that a perindopril erbumine hydrate is dissolved in water or a mixture of water and alcohol; an alkaline stabiliser solution and inert ingredients is added to this solution for producing a granulate, dried in vacuum or in air flow at 40°C and less to be granulated to produce granulate.
EFFECT: formulations have higher stability.
16 cl, 7 dwg, 1 tbl, 13 ex
Authors
Dates
2011-09-27—Published
2006-11-08—Filed